EHRA Premium Access

Appropriate and inappropriate ICD therapy with evidence-based programming: a real-world comparison with trial data

Topic: Implantable Cardioverter-Defibrillator (ICD)

Congress Session

About the speaker

Doctor Michael Chapman

James Cook University Hospital, Middlesbrough (United Kingdom of Great Britain & Northern Ireland)
0 follower

14 more presentations in this session

Mid-term clinical outcomes of subcutaneous versus transvenous implantable defibrillator therapy in young patients.

Speaker: Mr J. Ramos Maqueda (Zaragoza, ES)


Implantable cardioverter defibrillator and resynchronisation therapy in patients with dilated cardiomyopathy:efficiency in prevention of sudden cardiac death


Time to therapy delivery and effectiveness of subcutaneous implantable cardioverter defibrillator.

Speaker: Associate Professor I. Diemberger (Bologna, IT)


Determinants of battery longevity of internal cardioverter defibrillators with and without cardiac resynchronization capabilities

Speaker: Doctor R. Brenner (St. Gallen, CH)


Day case complex devices - The state of the UK

Speaker: Doctor M. Waight (London, GB)


Access the full session

Poster session 2 - Implantable Cardioverter / Defibrillator

Speakers: Doctor M. Chapman, Mr J. Ramos Maqueda, Associate Professor I. Diemberger, Doctor R. Brenner, Doctor M. Waight

About the event


EHRA 2019

17 March - 19 March 2019

Sessions Presentations

This platform is supported by

logo Novo Nordisk